| Identity |
| Other names | Myopodin |
| synaptopodin 2 | |
| Hugo | SYNPO2 |
| Location | 4q27 |
| Note | Myopodin probably represents an alternative splicing variant of synaptopodin 2. The predicted synaptopodin 2 contains 1021 amino acid and myopodin 698. The extra 323 amino acid in synaptopodin 2 is located at the N-terminus. |
| DNA/RNA |
![]() | |
| Genome structure of myopodin and synaptopodin 2. Green represents exons of myopodin, and orange synaptopodin 2. Introns are indicated with lines. | |
| Description | The genome sequence of myopodin contains 6.8 Kb, while synaptopodin 2 38 kb. |
| Transcription | A typical messenger RNA of myopodin is 4.2-4.4 kb, and synaptopodin 2 6.7 kb. |
| Pseudogene | Unknown |
| Protein |
![]() | |
| Protein structure of myopodin and synaptopodin 2. Orange represents sequence unique to synaptopodin 2, Green myopodin. Black stripe represents sequence homologous to synaptopodin 1. | |
| Description | A nuclear localization signal is identified in N-terminus region of myopodin. Myopodin also contains six stretches of homologous sequences with synaptopodin 1. |
| Expression | Skeletal muscle, prostate, large and small intestine. |
| Localisation | Nucleus, cytoplasm. |
| Function | Actin bundling. |
| Homology | Synaptopodin |
| Mutations |
| Germinal | Not known |
| Somatic | Deletion |
| Implicated in |
| Disease | Prostate cancer and urothelial cell carcinoma. |
| Prognosis | Deletion preferentially occurs in aggressive type of prostate cancer. Loss of expression in nucleus in urothelial cell carcinoma is predictive of poor clinical outcome. |
| Cytogenetics | Not known |
| External links |
| Bibliography |
| Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers. |
| Lin F, Yu YP, Woods J, Cieply K, Gooding B, Finkelstein P, Dhir R, Krill D, Becich MJ, Michalopoulos G, Finkelstein S, Luo JH |
| The American journal of pathology. 2001 ; 159 (5) : 1603-1612. |
| PMID 11696420 |
| Differentiation- and stress-dependent nuclear cytoplasmic redistribution of myopodin, a novel actin-bundling protein. |
| Weins A, Schwarz K, Faul C, Barisoni L, Linke WA, Mundel P |
| The Journal of cell biology. 2001 ; 155 (3) : 393-404. |
| PMID 11673475 |
| Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome. |
| Sanchez-Carbayo M, Schwarz K, Charytonowicz E, Cordon-Cardo C, Mundel P |
| Oncogene. 2003 ; 22 (34) : 5298-5305. |
| PMID 12917631 |
| REVIEW articles | automatic search in PubMed |
| Last year publications | automatic search in PubMed |
| Contributor(s) |
| Written | 12-2003 | Jian-Hua Luo |
| Citation |
| This paper should be referenced as such : |
| Luo JH . SYNPO2. Atlas Genet Cytogenet Oncol Haematol. December 2003 . URL : http://AtlasGeneticsOncology.org/Genes/SYNPO2ID488.html |
| © Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Mon Jul 14 17:50:43 2008 |
For comments and suggestions or contributions, please contact us